Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis

PLoS Neglected Tropical Diseases

Volumn 5, Issue 5, 2011, Pages

  Suputtamongkol, Yupin ^a   Premasathian, Nalinee ^a   Bhumimuang, Kid ^a   Waywa, Duangdao ^a   Nilganuwong, Surasak ^a   Karuphong, Ekkapun ^a   Anekthananon, Thanomsak ^a   Wanachiwanawin, Darawan ^a   Silpasakorn, Saowaluk ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; IVERMECTIN; UNCLASSIFIED DRUG; VERMECTIN; ANTHELMINTIC AGENT;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FECES ANALYSIS; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOLID TUMOR; STRONGYLOIDIASIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THAILAND; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ANIMAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FECES; METHODOLOGY; MICROSCOPY; MIDDLE AGED; PARASITOLOGY; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; FECES; FEMALE; HUMANS; IVERMECTIN; MALE; MICROSCOPY; MIDDLE AGED; PARASITOLOGY; PROSPECTIVE STUDIES; STRONGYLOIDIASIS; THAILAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 79958002079     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001044     Document Type: Article

References (22)

1. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, et al. (2006) Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367: 1521-1532.
2. Sithithaworn P, Srisawangwong T, Tesana S, Daenseekaew W, Sithithaworn J, et al. (2003) Epidemiology of Strongyloides stercoralis in north-east Thailand: application of the agar plate culture technique compared with the enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 97: 398-402.
3. Concha R, Harrington W, Rogers AI, (2005) Intestinal strongyloidiasis: recognition, management, and determinants of outcomes. J Clin Gastroenterol 39: 203-211.
4. Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, et al. (2006) Impairment of host immune response against Strongyloides stercoralis by human T cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 74: 246-9.
5. Keiser PB, Nutman TB, (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17: 208-17.
6. Roxby AC, Gottlieb GS, Limaye AP, (2009) Strongyloidiasis in transplant patients. Clin Infect Dis 49: 1411-1423.
7. Seybolt LM, Christiansen D, Barnett ED, (2006) Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis 42: 363-367.
8. Siddiqui AA, Berk SL, (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33: 1040-1047.
9. Ebrahim A, El-Morshedy H, Omer E, El-Daly S, Barakat R, (1997) Evaluation of the Kato-Katz thick smear and formol ether sedimentation techniques for quantitative diagnosis of Schistosoma mansoni infection. Am J Trop Med Hyg 57: 706-708.
10. Koga K, Kasuya S, Khamboonruang C, Sukhavat K, Ieda M, et al. (1991) A modified agar plate method for detection of Strongyloides stercoralis. Am J Trop Med Hyg 45: 518-521.
11. Knopp S, Mgeni AF, Khamis IS, Steinmann P, Stothard JR, et al. (2008) Diagnosis of Soil-Transmitted Helminths in the Era of Preventive Chemotherapy: Effect of Multiple Stool Sampling and Use of Different Diagnostic Techniques. PLoS Negl Trop Dis 2 (11): e331:10.1371/journal.pntd.0000331.
12. Rossignol JF, Maisonneuve H, (1983) Albendazole: placebo controlled study in 870 patients with intestinal helminthiasis. Trans R Soc Trop Med Hyg 77: 707-711.
13. Pungpak S, Bunnag D, Chindanond D, Radmoyos B, (1987) Albendazole in the treatment of strongyloidiasis. Southeast Asian J Trop Med Public Health 18: 207-210.
14. Archibald LK, Beeching NJ, Gill GV, Bailey JW, Bell DR, (1993) Albendazole is effective treatment for chronic strongyloidiasis. Q J Med 86: 191-195.
15. Pitisuttithum P, Supanaranond W, Chindanond DA, (1995) Randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health 26: 735-738.
16. Gann PH, Neva FA, Gam AA, (1994) A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 169: 1076-1079.
17. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, Lyagoubi M, Gaxotte P, et al. (1994) Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 89: 344-345.
18. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, et al. (1996) A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55: 477-481.
19. Toma H, Sato Y, Shiroma Y, Kobayashi J, Shimabukuro I, et al. (2000) Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan. Southeast Asian J Trop Med Public Health 31: 147-151.
20. Nontasut P, Muennoo C, Sa-nguankiat S, Fongsri S, Vichit A, (2005) Prevalence of Strongyloides in northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health 36: 442-444.
21. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ, (2008) Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7- day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents 31: 46-49.
22. Zaha O, Hirata T, Kinjo F, Saito A, Fukuhara H, (2002) Efficacy of ivermectin for chronic strongyloidiasis: two single doses given 2 weeks apart. J Infect Chemother 8: 94-98.